(Total Views: 102)
Posted On: 06/20/2023 12:30:46 PM
Post# of 104084
$ANVS News Article - Annovis Bio Receives Excellent Safety Rating and Positive Recommendation to Continue Phase III Trial of Buntanetap for Parkinson's Disease Patients from the Independent Data and Safety Monitoring Board (DSMB) https://marketwirenews.com/news-releases/anno...97093.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
